Yuhao Luo Kelin Mou Jianmei Wang Jing Luo Lin Peng Hua Ye Sheng Lin
10.3389/fimmu.2022.970879
Front Immunol
2022 Aug 8;13:970879.
braf v600e colon metastasis immunotherapy nsclc pd-1
CC BY
https://pubmed.ncbi.nlm.nih.gov/36003386/
Adenocarcinoma of Lung / drug therapy Adenocarcinoma of Lung / genetics Colonic Neoplasms / drug therapy Colonic Neoplasms / therapy Lung Neoplasms / drug therapy Lung Neoplasms / therapy Rectal Neoplasms / drug therapy
Adenocarcinoma of Lung / drug therapy Adenocarcinoma of Lung / genetics Colonic Neoplasms / drug therapy Colonic Neoplasms / therapy Lung Neoplasms / drug therapy Lung Neoplasms / therapy Rectal Neoplasms / drug therapy Case Reports Research Support, Non-U.S. Gov't Antineoplastic Combined Chemotherapy Protocols / therapeutic use B7-H1 Antigen / genetics Humans Imidazoles / therapeutic use Middle Aged Mutation Oximes / therapeutic use Proto-Oncogene Proteins B-raf / genetics Pyridones / therapeutic use Pyrimidinones / therapeutic use B7-H1 Antigen Imidazoles Oximes Pyridones Pyrimidinones BRAF protein, human Proto-Oncogene Proteins B-raf
PMC9393296
36003386
Colon metastasis from lung adenocarcinoma with BRAF V600E mutation: A case report
2022